Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Momenta Pharmaceuticals, Inc.
  6. Summary
    MNTA   US60877T1007

MOMENTA PHARMACEUTICALS, INC.

(MNTA)
End-of-day quote Nasdaq  -  2020-09-29
52.48 USD   -0.02%
2020JOHNSON & JOHNSON : Completes Acquisition of Momenta Pharmaceuticals, Inc.; Acquisition broadens Janssen's leadership in autoimmune diseases and provides a major catalyst for sustained growth
AQ
2020MOMENTA PHARMACEUTICALS : Announces Completion of Proposed Sale to Johnson & Johnson
AQ
2020JOHNSON & JOHNSON : Completes Acquisition of Momenta Pharmaceuticals, Inc.
AQ
 SummaryChartsNewsCompany 
Company
Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company is focused on developing generic versions of drugs, biosimilars and therapeutics for oncology and autoimmune disease. The Company has developed generic version of LOVENOX (enoxaparin sodium injection) and COPAXONE (glatiramer acetate injection). GLATOPA 20 milligrams (mg)/ milliliters (mL) is a generic version of once-daily COPAXONE 20 mg/mL... 
Read more
More about the company
All news about MOMENTA PHARMACEUTICALS, INC.
2020JOHNSON & JOHNSON : Completes Acquisition of Momenta Pharmaceuticals, Inc.; Acquisition br..
AQ
2020MOMENTA PHARMACEUTICALS : Announces Completion of Proposed Sale to Johnson & Johnson
AQ
2020JOHNSON & JOHNSON : Completes Acquisition of Momenta Pharmaceuticals, Inc.
AQ
2020MOMENTA PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice o..
AQ
2020Momenta Pharmaceuticals, Inc. Announces Executive Changes
CI
2020MOMENTA PHARMACEUTICALS : Announces Completion of Proposed Sale to Johnson & Johnson
AQ
2020Momenta Pharmaceuticals Announces Completion of Proposed Sale to Johnson & Johnson
GL
2020MOMENTA PHARMACEUTICALS, INC.(NASDAQ : MNTA) dropped from Russell Small Cap Comp Value Ind..
CI
2020MOMENTA PHARMACEUTICALS, INC.(NASDAQ : MNTA) dropped from Russell Small Cap Comp Growth In..
CI
2020MOMENTA PHARMACEUTICALS, INC.(NASDAQ : MNTA) dropped from Russell 3000 Value Index
CI
2020MOMENTA PHARMACEUTICALS, INC.(NASDAQ : MNTA) dropped from Russell 2500 Value Index
CI
2020MOMENTA PHARMACEUTICALS, INC.(NASDAQ : MNTA) dropped from Russell 2000 Value Index
CI
2020MOMENTA PHARMACEUTICALS, INC.(NASDAQ : MNTA) dropped from S&P Biotechnology Select Industr..
CI
2020MOMENTA PHARMACEUTICALS, INC.(NASDAQ : MNTA) dropped from S&P 600
CI
2020MOMENTA PHARMACEUTICALS, INC.(NASDAQ : MNTA) dropped from S&P Composite 1500
CI
More news
News in other languages on MOMENTA PHARMACEUTICALS, INC.
2020WALL STREET : clôture dans le rouge après les minutes du FOMC
2020Wall Street finit en baisse, la Fed reste inquiète pour l'économie
2020Point marchés-Wall Street finit en baisse, la Fed reste inquiète pour l'économie
2020VALNEVA, plus forte hausse du SRD à la clôture du mercredi 19 août 2020
2020Borsa Usa, S&P 500 ancora ai massimi dopo utili Target e Lowe
More news
Analyst Recommendations on MOMENTA PHARMACEUTICALS, INC.
More recommendations
Chart MOMENTA PHARMACEUTICALS, INC.
Duration : Period :
Momenta Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
Anthony M. Manning Chief Scientific Officer
Susan Hohenleitner Director
Duane van Arsdale Director
Jonathan Bryant Director
Patty Eisenhaur Investor Relations Contact
Sector and Competitors
1st jan.Capi. (M$)
MOMENTA PHARMACEUTICALS, INC.0.00%6 247
MODERNA, INC.-43.20%57 385
IQVIA HOLDINGS INC.-24.22%40 468
LONZA GROUP AG-32.67%39 851
SEAGEN INC.16.00%33 010
CELLTRION, INC.-13.38%18 371